COMPOUND WITH CONFIDENCE: PCCA Membership, $795/month.
Stay current on PCCA news and events, market trends, and all things compounding!
Our four-part series continues with Part 2, USP 795 revisions and impacts on compounding pharmacies.
Matt Martin, PharmD, BCSCP, PCCA Director of Clinical Services, reviews USP 795 & 800 revisions and impacts on compounding pharmacies in the first of a four-part series.
PCCA Director of Formulations Melissa Merrell Rhoads, PharmD, offers insights on working with SuspendIt Anhydrous in oral suspension formulations
Congratulations to Steve Hoffart, PharmD, of Magnolia Pharmacy, Magnolia, Texas, for hitting a double-home run! In October, he was awarded PCCA’s 2022 Pharmacist of the Year and is January’s Profile in Personalized Medicine.
A modular compounding cleanroom is a great way to meet evolving regulatory requirements and standards. Learn the basics of a modular cleanroom in the first in a series of articles on Modular Compounding Cleanrooms.
Our PCCA Clinical Compounding Pharmacist Don Bottoni continues to discuss the gut-brain connection and ways to restore gut health.
Our PCCA Clinical Compounding Pharmacist Don Bottoni reviews the gut-brain connection and how it plays a major role in health and disease.
PCCA Senior Formulation Pharmacist Fabiana Banov offers flavoring tips that may make medicines tastier for children, pets and adults.
Congratulations to Chris Gilbert, PharmD, of People’s Custom Rx in Memphis, Tennessee for being our December Profile in Personalized Medicine. These profiles celebrate members of the PCCA family who have proven to be champions of pharmacy compounding by providing the highest quality of service to their patients.
Clarification from the FDA and our industry partner, APC, reinstates sales and shipments of Thyroid USP (Porcine) (PCCA #30-1467) to compounding pharmacies.